We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04696731
Brief Title: Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma (TRAVERSE)

First Submitted : January 4, 2021
First Submitted that Met QC Criteria : January 4, 2021
First Posted : January 6, 2021

Last Update Submitted that Met QC Criteria : March 25, 2022
Last Update Posted : March 29, 2022